A detailed history of Xtx Topco LTD transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Xtx Topco LTD holds 15,564 shares of PRTA stock, worth $252,292. This represents 0.02% of its overall portfolio holdings.

Number of Shares
15,564
Holding current value
$252,292
% of portfolio
0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$16.73 - $24.79 $260,385 - $385,831
15,564 New
15,564 $260,000
Q4 2023

Feb 13, 2024

SELL
$32.31 - $52.32 $124,328 - $201,327
-3,848 Reduced 34.63%
7,264 $263,000
Q3 2023

Nov 13, 2023

BUY
$47.3 - $70.6 $525,597 - $784,507
11,112 New
11,112 $536,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $761M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.